Citius Pharmaceuticals, Inc. Shareholders' Equity
Citius Pharmaceuticals, Inc. (CTXR) had Shareholders' Equity of $66.61 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $66.61M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $61.54M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $79.96M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $67.55M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $66.61M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $61.54M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $79.96M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $67.55M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $65.06M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $60.66M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $65.41M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $70.08M 10-K · filed 2025-12-23 | |
| 2024-06-30 | $85.68M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $79.37M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $84.73M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $90.83M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $97.70M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $91.21M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $100.43M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $102.83M 10-K · filed 2023-12-29 | |
| 2022-06-30 | $109.74M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $117.60M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $123.96M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $132.18M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $136.68M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $125.16M 10-Q · filed 2021-05-13 | |
| 2020-09-30 | $33.67M 10-K · filed 2021-12-15 | |
| 2020-06-30 | $28.74M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $25.22M 10-Q · filed 2020-08-14 | $22.44M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $23.15M 10-Q · filed 2020-08-14 | $20.38M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $27.15M 10-K · filed 2020-12-16 | $24.38M 10-K · filed 2019-12-16 |
| 2019-06-30 | $24.28M 10-Q · filed 2020-08-14 | $21.51M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $23.65M 10-Q · filed 2020-08-14 | $20.87M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $26.95M 10-Q · filed 2020-08-14 | $24.18M 10-Q · filed 2019-02-14 |
| 2018-09-30 | $30.64M 10-K · filed 2020-12-16 | $27.87M 10-K · filed 2018-12-11 |
| 2018-06-30 | $21.64M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $23.50M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $25.86M 10-Q · filed 2019-08-14 | |
| 2017-09-30 | $21.95M 10-K · filed 2019-12-16 | |
| 2017-06-30 | $11.59M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $13.99M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $15.16M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $16.77M 10-K · filed 2019-12-16 | |
| 2016-06-30 | $18.16M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $20.43M 10-Q · filed 2016-05-20 | |
| 2015-12-31 | -$1.59M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | -$635.21K 10-K · filed 2018-12-11 | |
| 2015-06-30 | -$1.18M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$918.02K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | -$823.55K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | -$741.93K 10-K · filed 2017-12-13 | |
| 2014-06-30 | -$31.35K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$25.05K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$2.90M 10-K · filed 2016-12-23 | -$15.05K 10-Q · filed 2014-02-19 |
| 2013-09-30 | -$14.69K 10-Q · filed 2014-08-14 | |
| 2013-06-30 | -$61.93K 10-Q · filed 2013-09-18 | |
| 2013-03-31 | -$57.50K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | -$1.61M 10-K · filed 2015-12-14 | -$47.27K 10-Q · filed 2013-02-08 |
| 2012-09-30 | -$45.85K 10-Q · filed 2014-08-14 | |
| 2012-06-30 | -$40.45K 10-Q · filed 2012-08-17 | |
| 2012-03-31 | -$33.62K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$1.06M 10-KT · filed 2014-12-29 | -$26.41K 10-Q · filed 2012-02-14 |
| 2011-09-30 | -$23.84K 10-Q · filed 2014-05-15 | |
| 2011-06-30 | -$23.84K 10-K · filed 2012-01-13 | -$21.08K 10-Q · filed 2011-08-26 |
| 2010-09-30 | $2.50K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |